
|Videos|October 1, 2015
Preparing for Your BRCA Testing
Advertisement
Advertisement
Related to this article

The FDA approved Wilserdly with everolimus for some ER-positive, HER2-negative, ESR1-mutated advanced breast cancers that grew after prior hormone therapy.

City of Hope experts share integrative therapies that may ease breast cancer side effects such as joint pain, hot flashes, poor sleep, fatigue and anxiety.

City of Hope experts explain integrative oncology in breast cancer: when to consider it, why it won't replace treatment and what to know about supplements.

A mother whose daughter is seven years past breast cancer treatment shares how scan anxiety and waiting shape life after cancer for survivors and families.

A review of 29 studies in more than 22,000 women 65 and older with ER-positive breast cancer found no statistically significant survival difference between hormone therapy alone and surgery first, though surgery controlled the cancer in the breast better.

A 12-year breast cancer survivor with 16 tattoos, including radiation marks, weighs new research on tattoos and lymphoma risk and the questions it prompts.

Leanne Citrone shares how a BRCA mutation, an elective mastectomy and a stage 2C ovarian cancer diagnosis shaped her outlook, anxiety and advice to others.
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Wilserdly Combo for ESR1-Mutated Breast Cancer
2
5 Ways to Cope With Scanxiety While Waiting for Cancer Results
3
Breast Cancer Side Effects: Integrative Therapies That May Help
4
Integrative Oncology and Breast Cancer: What Patients Should Know
5







